| pubmed-article:6146625 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6146625 | lifeskim:mentions | umls-concept:C0006675 | lld:lifeskim |
| pubmed-article:6146625 | lifeskim:mentions | umls-concept:C0007412 | lld:lifeskim |
| pubmed-article:6146625 | lifeskim:mentions | umls-concept:C0028066 | lld:lifeskim |
| pubmed-article:6146625 | lifeskim:mentions | umls-concept:C1704675 | lld:lifeskim |
| pubmed-article:6146625 | lifeskim:mentions | umls-concept:C0428883 | lld:lifeskim |
| pubmed-article:6146625 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:6146625 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
| pubmed-article:6146625 | lifeskim:mentions | umls-concept:C1550548 | lld:lifeskim |
| pubmed-article:6146625 | lifeskim:mentions | umls-concept:C1555714 | lld:lifeskim |
| pubmed-article:6146625 | lifeskim:mentions | umls-concept:C1705654 | lld:lifeskim |
| pubmed-article:6146625 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6146625 | pubmed:dateCreated | 1984-9-19 | lld:pubmed |
| pubmed-article:6146625 | pubmed:abstractText | In the pithed normotensive rat the effect of the calcium entry blocker nifedipine was studied on alpha 1-adrenoreceptor-mediated pressor responses of intravenously administered (-)-noradrenaline, dopamine and (-)-adrenaline as well as of (-)-noradrenaline released from sympathetic neurones by DMPP, tyramine, McN-A-343 and electrical stimulation of the spinal cord at the level Th5-L4. The alpha 1-adrenoreceptor-mediated pressor responses to both intravenously administered and neuronally released catecholamines were moderately antagonized by nifedipine. The alpha 1-adrenoreceptor-mediated increase in diastolic pressure elicited by DMPP was unique in its extreme insensitivity to blockade by nifedipine. The results support the hypothesis that phenylethylamine-like alpha 1-adrenoreceptor agonists induce an increase in diastolic pressure relatively independent of extracellular calcium in contrast to imidazolidine-like agonists. The data may be interpreted as indicating that each alpha 1-adrenoreceptor agonist activates the alpha 1-adrenoreceptor in a unique way. | lld:pubmed |
| pubmed-article:6146625 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6146625 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6146625 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6146625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6146625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6146625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6146625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6146625 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6146625 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:6146625 | pubmed:issn | 0144-1795 | lld:pubmed |
| pubmed-article:6146625 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:6146625 | pubmed:author | pubmed-author:TimmermansP... | lld:pubmed |
| pubmed-article:6146625 | pubmed:author | pubmed-author:De JongeAA | lld:pubmed |
| pubmed-article:6146625 | pubmed:author | pubmed-author:WilffertBB | lld:pubmed |
| pubmed-article:6146625 | pubmed:author | pubmed-author:ThoolenM JMJ | lld:pubmed |
| pubmed-article:6146625 | pubmed:author | pubmed-author:DavideskoDD | lld:pubmed |
| pubmed-article:6146625 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6146625 | pubmed:volume | 4 | lld:pubmed |
| pubmed-article:6146625 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6146625 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6146625 | pubmed:pagination | 87-92 | lld:pubmed |
| pubmed-article:6146625 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:meshHeading | pubmed-meshheading:6146625-... | lld:pubmed |
| pubmed-article:6146625 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6146625 | pubmed:articleTitle | Interaction between the calcium entry blocker nifedipine with the alpha 1-adrenoreceptor-mediated increase in diastolic pressure elicited by catecholamines. | lld:pubmed |
| pubmed-article:6146625 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6146625 | lld:pubmed |
